Clinical Trials List
2017-05-01 - 2020-07-31
Phase III
Recruiting2
Terminated8
ICD-10C34
Malignant neoplasm of bronchus and lung
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chi-Lu Chiang Division of Thoracic Medicine
- Chao-Hua Chiu Division of Thoracic Medicine
- Heng-Sheng Chao Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
9 Recruiting
Audit
CRO
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Wei-Pang Chung Division of Thoracic Medicine
- Shang-Yin Wu Division of Thoracic Medicine
- Jui-Hung Tsai Division of Thoracic Medicine
- Yu-Min Yeh Division of Thoracic Medicine
- Seu-Chun Yang Division of Thoracic Medicine
- Wen-Pin Su Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林宗哲 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 廖唯昱 Division of Hematology & Oncology
- 吳尚俊 Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- TSUNG -YING YANG Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 廖偉志 Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
- Chih-Yen Tu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 趙東瀛 Division of Hematology & Oncology
- Chia-Cheng Tseng Division of Hematology & Oncology
- Shau-Hsuan Li Division of Radiology
- 王逸熙 Division of Hematology & Oncology
- 張晃智 Division of Thoracic Medicine
- 陳彥豪 Division of Radiology
- Ying-Huang Tsai Division of Radiology
- 林孟志 Division of Hematology & Oncology
- 賴建豪 Division of Thoracic Medicine
- 饒坤銘 Division of Hematology & Oncology
- 林理涵 Division of Radiology
- 鍾聿修 Division of Thoracic Medicine
- 黃國棟 Division of Hematology & Oncology
- 李易濰 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- Ching-Shan Luo Division of Thoracic Medicine
- Tzu-Tao Chen Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- Chien-Hua Tseng Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
15 Terminated
Audit
CRO
Taiwan National PI
Co-Principal Investigator
- Chien-Ying Liu Division of Infectious Disease
- Chih-Hsi Kuo Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Chih-Liang Wang Division of Radiology
- 枋岳甫 Division of Hematology & Oncology
- Chih-Hung Chen Division of Radiology
- Chih-Hung Chen Division of Radiology
- Ping-Chih Hsu Division of Hematology & Oncology
- 黃振洋 Division of Radiology
- Wen-Cheng Chang Division of Infectious Disease
- 柯皓文 Division of Hematology & Oncology
- 謝任富 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
12 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
1000 participants
